We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Peptides, Lipopeptides Used to Fight Bacteria

By Biotechdaily staff writers
Posted on 26 Jan 2007
By combining major characteristics of two different types of tools used by the innate defense systems of organisms, a team of scientists has managed to devise a more powerful weapon, hoping that this will provide a basis for more innovative and effective antibiotics. More...


The first is a "magnetic” weapon--a natural antibiotic produced by all organisms. Because these antimicrobial peptides (AMPs) are positively charged, they are attracted to the bacteria's negatively charged surface similar to a magnet, where they can then exert their antibacterial effects. The second, "detergent-like” weapon, called a lipopeptide, is produced only by bacteria and fungi, which, due to a negative charge, target mainly fungi. This weapon contains a fatty acid chain that, similar to chains in soap that dissolve dirt and oils, breaks down the fatty membranes of the fungi.

In the study, published in the October 12, 2006, issue of the journal Proceedings of the [U.S.] National Academy of Sciences (PNAS), Prof. Yechiel Shai and Ph.D. students Arik Makovitzki and Dorit Avrahami from the biological chemistry department at the Weizmann Institute of Science (Rehovot, Israel) have effectively combined the properties of AMPs with lipopeptides, resulting in a synthetic lipopeptide that has both a positive charge and the soap-like ability to dissolve oils.

By changing the length of the fatty acid chains and the sequence of positively charged amino acids, the investigators were able to create a range of weapons. Some are active against both bacteria and fungi, whereas others target just one or the other. Furthermore, they managed to design these new synthetic peptides (protein fragments) to contain only four amino acids, as opposed to the 12-50 found in their natural forms.

These results will hopefully provide a whole new range of potential applications. The short length of the synthetic peptide makes it appealing for drug design as it would be both easier and economically less expensive to synthesize, less prone to resistance, and potentially engineered to target a large array of bacterial and fungal infections.



Related Links:
Weizmann Institute of Science

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
Blood-Based Protein Biomarker Solution for Alzheimer's Disease
BG-DTi2000.
Pipette Calibration System
Artel PCS®
Manual Pipetting Aid
Pipette Controllers macro
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Nian Sun has spent years perfecting a device that he believes could change the way diseases are detected. (Photo courtesy of Alyssa Stone/Northeastern University)

Rapid Breath Sensor Detects SARS-CoV-2 from Exhaled Air

Nasal swabs and polymerase chain reaction (PCR) testing have been central to identifying SARS-CoV-2, but they can be uncomfortable, slow, and logistically complex when samples require transport.... Read more

Molecular Diagnostics

view channel
Image Credit: Adobe Stock

Comprehensive Genomic Testing Expands Treatment Options for Advanced Cancers

Selecting effective therapies for advanced cancers remains difficult because standard tumor testing often targets only a limited set of genes. As options dwindle, many patients face decisions without strong... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.